Raymond H. Mak

Citée par

	Toutes	Depuis 2019
Citations	25070	12284
indice h	49	41
indice i10	105	98

2300

1150

575

1725

2005200620072008200920102011201220132014201520162017201820192020202120222023202473 245 332 490 635 818 950 1200 1223 1297 1258 1294 1394 1409 1558 1885 2230 2196 2292 2069

Accès public

Tout afficher

65 articles

4 articles

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Hugo AertsDirector AI in Medicine (AIM) @ Harvard-MGB | Professor @ MaastrichtUAdresse e-mail validée de dfci.harvard.edu
David KozonoAdresse e-mail validée de lroc.harvard.edu
Danielle S. BittermanHarvard Medical SchoolAdresse e-mail validée de dfci.harvard.edu
Thibaud CorollerResearcher @ NovartisAdresse e-mail validée de novartis.com
Benjamin H KannDana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical SchoolAdresse e-mail validée de dfci.harvard.edu
Benjamin L. EbertDana-Farber Cancer InstituteAdresse e-mail validée de dfci.harvard.edu
Todd GolubBroad InstituteAdresse e-mail validée de broadinstitute.org
Elizabeth HuynhLondon Regional Cancer ProgramAdresse e-mail validée de lhsc.on.ca
Ahmed HosnyMachine Learning @ Dana Farber Cancer InstituteAdresse e-mail validée de dfci.harvard.edu
Christopher L. WilliamsNASAAdresse e-mail validée de bwh.harvard.edu
Christian GuthierDana-Farber/Brigham and Women's Cancer Center/ Harvard UniversityAdresse e-mail validée de dfci.harvard.edu
Udo HoffmannProfessor of Radiology, Harvard University, Massachusetts General HospitalAdresse e-mail validée de mgh.harvard.edu
Chintan ParmarAstraZeneca (past: PathAI, Novartis, Harvard-DFCI-BWH, ISI-Kolkata, DAIICT)Adresse e-mail validée de astrazeneca.com
Tafadzwa L ChaunzwaHarvard Medical SchoolAdresse e-mail validée de dfci.harvard.edu
Roman ZeleznikPost Doc, Brigham and Women's Hospital, Harvard Medical SchoolAdresse e-mail validée de bwh.harvard.edu
Jeremy BredfeldtHarvard UniversityAdresse e-mail validée de bwh.harvard.edu
Idalid FrancoResident, Harvard Radiation Oncology ProgramAdresse e-mail validée de partners.org
Anju NohriaBrigham and Women's HospitalAdresse e-mail validée de partners.org
Emmanuel Rios VelazquezBusiness Development Manager - Precision Health & Nutrition @imec - OnePlanet Research CenterAdresse e-mail validée de imec.nl
"Jonathan E. Leeman"Dana-Farber/Brigham and Women's Cancer CenterAdresse e-mail validée de dfci.harvard.edu

Suivre

Raymond H. Mak

Associate Professor of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute

Adresse e-mail validée de lroc.harvard.edu - Page d'accueil

Radiation Oncology Artificial Intelligence


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
MicroRNA expression profiles classify human cancers J Lu, G Getz, EA Miska, E Alvarez-Saavedra, J Lamb, D Peck, ... nature 435 (7043), 834-838, 2005	11963	2005
Artificial intelligence in cancer imaging: clinical challenges and applications WL Bi, A Hosny, MB Schabath, ML Giger, NJ Birkbak, A Mehrtash, ... CA: a cancer journal for clinicians 69 (2), 127-157, 2019	1480	2019
Densely interconnected transcriptional circuits control cell states in human hematopoiesis N Novershtern, A Subramanian, LN Lawton, RH Mak, WN Haining, ... Cell 144 (2), 296-309, 2011	1075	2011
CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma TP Coroller, P Grossmann, Y Hou, ER Velazquez, RTH Leijenaar, ... Radiotherapy and Oncology 114 (3), 345-350, 2015	771	2015
Robust radiomics feature quantification using semiautomatic volumetric segmentation C Parmar, E Rios Velazquez, R Leijenaar, M Jermoumi, S Carvalho, ... PloS one 9 (7), e102107, 2014	649	2014
Deep learning predicts lung cancer treatment response from serial medical imaging Y Xu, A Hosny, R Zeleznik, C Parmar, T Coroller, I Franco, RH Mak, ... Clinical Cancer Research 25 (11), 3266-3275, 2019	532	2019
Deep learning for lung cancer prognostication: a retrospective multi-cohort radiomics study A Hosny, C Parmar, TP Coroller, P Grossmann, R Zeleznik, A Kumar, ... PLoS medicine 15 (11), e1002711, 2018	521	2018
Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology … RH Mak, D Hunt, WU Shipley, JA Efstathiou, WJ Tester, MP Hagan, ... Journal of Clinical Oncology 32 (34), 3801-3809, 2014	483	2014
MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors J Lu, S Guo, BL Ebert, H Zhang, X Peng, J Bosco, J Pretz, R Schlanger, ... Developmental cell 14 (6), 843-853, 2008	424	2008
Exploratory study to identify radiomics classifiers for lung cancer histology W Wu, C Parmar, P Grossmann, J Quackenbush, P Lambin, J Bussink, ... Frontiers in oncology 6, 71, 2016	401	2016
Somatic mutations drive distinct imaging phenotypes in lung cancer E Rios Velazquez, C Parmar, Y Liu, TP Coroller, G Cruz, O Stringfield, ... Cancer research 77 (14), 3922-3930, 2017	370	2017
Radiomic phenotype features predict pathological response in non-small cell lung cancer TP Coroller, V Agrawal, V Narayan, Y Hou, P Grossmann, SW Lee, ... Radiotherapy and oncology 119 (3), 480-486, 2016	338	2016
Artificial intelligence in radiation oncology E Huynh, A Hosny, C Guthier, DS Bitterman, SF Petit, DA Haas-Kogan, ... Nature Reviews Clinical Oncology 17 (12), 771-781, 2020	303	2020
Volumetric CT-based segmentation of NSCLC using 3D-Slicer ER Velazquez, C Parmar, M Jermoumi, RH Mak, A Van Baardwijk, ... Scientific reports 3 (1), 3529, 2013	243	2013
Radiomic-based pathological response prediction from primary tumors and lymph nodes in NSCLC TP Coroller, V Agrawal, E Huynh, V Narayan, SW Lee, RH Mak, ... Journal of Thoracic Oncology 12 (3), 467-476, 2017	236	2017
Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease JE Bradner, R Mak, SK Tanguturi, R Mazitschek, SJ Haggarty, K Ross, ... Proceedings of the National Academy of Sciences 107 (28), 12617-12622, 2010	231	2010
Cardiac radiation dose, cardiac disease, and mortality in patients with lung cancer KM Atkins, B Rawal, TL Chaunzwa, N Lamba, DS Bitterman, CL Williams, ... Journal of the American College of Cardiology 73 (23), 2976-2987, 2019	226	2019
CT-based radiomic analysis of stereotactic body radiation therapy patients with lung cancer E Huynh, TP Coroller, V Narayan, V Agrawal, Y Hou, J Romano, I Franco, ... Radiotherapy and Oncology 120 (2), 258-266, 2016	223	2016
An erythroid differentiation signature predicts response to lenalidomide in myelodysplastic syndrome BL Ebert, N Galili, P Tamayo, J Bosco, R Mak, J Pretz, S Tanguturi, ... PLoS medicine 5 (2), e35, 2008	203	2008
Deep learning classification of lung cancer histology using CT images TL Chaunzwa, A Hosny, Y Xu, A Shafer, N Diao, M Lanuti, DC Christiani, ... Scientific reports 11 (1), 1-12, 2021	190	2021

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs